Nanjing Nuoling Biotechnology

Nuoling Biotech is a clinical-stage biotechnology and medical device company based in Nanjing, China, specializing in innovative nitric oxide (NO) delivery systems. The company's core technology is a proprietary electrochemical platform that generates high-purity nitric oxide on-demand from ambient air, eliminating the logistical challenges of high-pressure gas cylinders. Their lead product, the INO-100, is designed for the treatment of persistent pulmonary hypertension in newborns and respiratory distress in cardiac surgery patients. Nuoling is also expanding its pipeline to include portable devices for chronic obstructive pulmonary disease and topical applications for chronic wound healing. The company aims to revolutionize gas-based therapies by making them more accessible for both hospital and home-care settings.